Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons

PLoS Genetics

Volumn 13, Issue 6, 2017, Pages

  Li, He ^a,b,ah,ai   Reksten, Tove Ragna ^a,c   Ice, John A ^a   Kelly, Jennifer A ^a   Adrianto, Indra ^a   Rasmussen, Astrid ^a   Wang, Shaofeng ^a   He, Bo ^a,b   Grundahl, Kiely M ^a   Glenn, Stuart B ^a   Miceli Richard, Corinne ^d   Bowman, Simon ^e   Lester, Sue ^f   Eriksson, Per ^g   Eloranta, Maija Leena ^h   Brun, Johan G ^c,i   Gøransson, Lasse G ^j   Harboe, Erna ^j   Guthridge, Joel M ^a   Kaufman, Kenneth M ^k,l   Kvarnström, Marika ^m   Cunninghame Graham, Deborah S ⁿ   Patel, Ketan ^o,p   Adler, Adam J ^a   Farris, A Darise ^a,b   Brennan, Michael T ^q   Chodosh, James ^r   Gopalakrishnan, Rajaram ^o   Weisman, Michael H ^s   Venuturupalli, Swamy ^s   Wallace, Daniel J ^s   Hefner, Kimberly S ^t   Houston, Glen D ^u,v   Huang, Andrew J W ^w   Hughes, Pamela J ^o   Lewis, David M ^u   Radfar, Lida ^u   Vista, Evan S ^a,x   Edgar, Contessa E ^y   Rohrer, Michael D ^o   Stone, Donald U ^z   Vyse, Timothy J ⁿ   Harley, John B ^k,l   Gaffney, Patrick M ^a   James, Judith A ^a,b   Turner, Sean ^a   Alevizos, Ilias ^aa   Anaya, Juan Manuel ^ab   Rhodus, Nelson L ^o   Segal, Barbara M ^ac   Montgomery, Courtney G ^a   Scofield, R Hal ^a,b,ad   Kovats, Susan ^a   Mariette, Xavier ^d   Rönnblom, Lars ^h   Witte, Torsten ^ae   Rischmueller, Maureen ^f,af   Wahren Herlenius, Marie ^m   Omdal, Roald ^j   Jonsson, Roland ^c,i   Ng, Wan Fai ^ag   Nordmark, Gunnel ^h   Lessard, Christopher J ^a,b   Sivils, Kathy L ^a,b   more..

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^f QUEEN ELIZABETH HOSPITAL   (Australia)

^g LINKÖPING UNIVERSITY   (Sweden)

^h UPPSALA UNIVERSITY   (Sweden)

ⁱ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^j STAVANGER UNIVERSITY HOSPITAL   (Norway)

^k CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ KING'S COLLEGE LONDON   (United Kingdom)

^o UNIVERSITY OF MINNESOTA   (United States)

^p NORTH MEMORIAL MEDICAL CENTER   (United States)

^q CAROLINAS MEDICAL CENTER   (United States)

^r HARVARD MEDICAL SCHOOL   (United States)

^s CEDARS SINAI MEDICAL CENTER   (United States)

^t Hefner Eye Care and Optical Center   (United States)

^u University of Oklahoma College of Dentistry   (United States)

^v Heartland Pathology Consultants   (United States)

^w WASHINGTON UNIVERSITY   (United States)

^x UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

^y Oklahoma Baptist University   (United States)

^z JOHNS HOPKINS UNIVERSITY   (United States)

^aa NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^ab UNIVERSIDAD DEL ROSARIO   (Colombia)

^ac UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^ad VETERANS AFFAIRS MEDICAL CENTER   (United States)

^ae HANNOVER MEDICAL SCHOOL   (Germany)

^af UNIVERSITY OF ADELAIDE   (Australia)

^ag NEWCASTLE UNIVERSITY   (United Kingdom)

^ah UNIVERSITY OF CALIFORNIA   (United States)

^ai NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; AUTOANTIBODY; INTERFERON; ISOPROTEIN; PROTEIN OAS1; PROTEIN P42; PROTEIN P44; PROTEIN P46; PROTEIN P48; RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG; OAS1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE FREQUENCY; GENE LOCUS; GENE SWITCHING; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS; SJOEGREN SYNDROME; TRANSLATION INITIATION; ALLELE; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM; PATHOLOGY; VIROLOGY; VIRUS INFECTION;

2',5'-OLIGOADENYLATE SYNTHETASE; ALLELES; ALTERNATIVE SPLICING; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON TYPE I; MALE; QUANTITATIVE TRAIT LOCI; SJOGREN'S SYNDROME; VIRUS DISEASES;

EID: 85021781632     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1006820     Document Type: Article

References (113)

1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15–25. doi: 10.1002/art.23177 18163481
2. Fox RI, Sjogren's syndrome. Lancet. 2005;366(9482):321–31. doi: 10.1016/S0140-6736(05)66990-5 16039337
3. Fox RI, Stern M, Michelson P, Update in Sjogren syndrome. Curr Opin Rheumatol. 2000;12(5):391–8. 10990175
4. Segal B, Thomas W, Rogers T, Leon JM, Hughes P, Patel D, et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjogren's syndrome. Arthritis Rheum. 2008;59(12):1780–7. doi: 10.1002/art.24311 19035421
5. Zintzaras E, Voulgarelis M, Moutsopoulos HM, The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165(20):2337–44. doi: 10.1001/archinte.165.20.2337 16287762
6. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT, Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis. 2006;65(6):796–803. doi: 10.1136/ard.2005.041186 16284097
7. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8. doi: 10.1136/ard.61.6.554 12006334
8. Toker E, Yavuz S, Direskeneli H, Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome. Br J Ophthalmol. 2004;88(3):384–7. doi: 10.1136/bjo.2003.028340 14977774
9. Hernandez-Molina G, Leal-Alegre G, Michel-Peregrina M, The meaning of anti-Ro and anti-La antibodies in primary Sjogren's syndrome. Autoimmun Rev. 2011;10(3):123–5. doi: 10.1016/j.autrev.2010.09.001 20833272
10. Kyriakidis NC, Kapsogeorgou EK, Tzioufas AG, A comprehensive review of autoantibodies in primary Sjogren's syndrome: clinical phenotypes and regulatory mechanisms. J Autoimmun. 2014;51:67–74. doi: 10.1016/j.jaut.2013.11.001 24333103
11. Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L, Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 2004;50(6):1861–72. doi: 10.1002/art.20254 15188363
12. Bave U, Nordmark G, Lovgren T, Ronnelid J, Cajander S, Eloranta ML, et al. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheumatol. 2005;52(4):1185–95.
13. Wiedeman AE, Santer DM, Yan W, Miescher S, Kasermann F, Elkon KB, Contrasting mechanisms of interferon-alpha inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists. Arthritis Rheum. 2013;65(10):2713–23. doi: 10.1002/art.38082 23840006
14. Nocturne G, Mariette X, Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol. 2013;9(9):544–56. doi: 10.1038/nrrheum.2013.110 23857130
15. Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. Nat Genet. 2013;45(11):1284–92. doi: 10.1038/ng.2792 24097067
16. Li Y, Zhang K, Chen H, Sun F, Xu J, Wu Z, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23. Nat Genet. 2013;45(11):1361–5. doi: 10.1038/ng.2779 24097066
17. Youinou P, Pers JO, Saraux A, Pennec YL, Viruses contribute to the development of Sjogren's syndrome. Clin Exp Immunol. 2005;141(1):19–20. doi: 10.1111/j.1365-2249.2005.02827.x 15958065
18. Igoe A, Scofield RH, Autoimmunity and infection in Sjogren's syndrome. Curr Opin Rheumatol. 2013;25(4):480–7. doi: 10.1097/BOR.0b013e32836200d2 23719365
19. Voulgarelis M, Tzioufas AG, Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome. Nat Rev Rheumatol. 2010;6(9):529–37. doi: 10.1038/nrrheum.2010.118 20683439
20. Theander E, Jonsson R, Sjostrom B, Brokstad K, Olsson P, Henriksson G, Prediction of Sjogren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling. Arthritis Rheumatol. 2015;67(9):2427–36. doi: 10.1002/art.39214 26109563
21. Poole BD, Scofield RH, Harley JB, James JA, Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006;39(1):63–70. doi: 10.1080/08916930500484849 16455583
22. Pasoto SG, Natalino RR, Chakkour HP, Viana Vdos S, Bueno C, Leon EP, et al. EBV reactivation serological profile in primary Sjogren's syndrome: an underlying trigger of active articular involvement?Rheumatol Int. 2013;33(5):1149–57. doi: 10.1007/s00296-012-2504-3 22955798
23. Mavragani CP, Sagalovskiy I, Guo Q, Nezos A, Kapsogeorgou EK, Lu P, et al. Long interspersed nuclear element-1 retroelements are expressed in patients with systemic autoimmune disease and induce type I interferon. Arthritis Rheumatol. 2016.
24. Reksten TR, Jonsson MV, Szyszko EA, Brun JG, Jonsson R, Brokstad KA, Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome. Rheumatology (Oxford). 2009;48(9):1102–6.
25. Ivashkiv LB, Donlin LT, Regulation of type I interferon responses. Nat Rev Immunol. 2014;14(1):36–49. doi: 10.1038/nri3581 24362405
26. Crow MK, Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res Ther. 2010;12Suppl 1:S5.
27. Ronnblom L, Eloranta ML, The interferon signature in autoimmune diseases. Curr Opin Rheumatol. 2013;25(2):248–53. doi: 10.1097/BOR.0b013e32835c7e32 23249830
28. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rustenburg F, Baggen JM, et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis. 2007;66(8):1008–14. doi: 10.1136/ard.2006.063412 17223656
29. van Baarsen LG, Wijbrandts CA, Rustenburg F, Cantaert T, van der Pouw Kraan TC, Baeten DL, et al. Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment. Arthritis Res Ther. 2010;12(1):R11. doi: 10.1186/ar2912 20096109
30. Raterman HG, Vosslamber S, de Ridder S, Nurmohamed MT, Lems WF, Boers M, et al. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients. Arthritis Res Ther. 2012;14(2):R95. doi: 10.1186/ar3819 22540992
31. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A. 2003;100(5):2610–5. doi: 10.1073/pnas.0337679100 12604793
32. Bauer JW, Baechler EC, Petri M, Batliwalla FM, Crawford D, Ortmann WA, et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med. 2006;3(12):e491. doi: 10.1371/journal.pmed.0030491 17177599
33. Ronnblom L, Alm GV, Eloranta ML, Type I interferon and lupus. Curr Opin Rheumatol. 2009;21(5):471–7. doi: 10.1097/BOR.0b013e32832e089e 19525849
34. Emamian ES, Leon JM, Lessard CJ, Grandits M, Baechler EC, Gaffney PM, et al. Peripheral blood gene expression profiling in Sjogren's syndrome. Genes & Immunity. 2009;10(4):285–96.
35. Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci U S A. 2006;103(8):2770–5. doi: 10.1073/pnas.0510837103 16477017
36. Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI, Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum. 2005;52(5):1534–44. doi: 10.1002/art.21006 15880807
37. Perez P, Anaya JM, Aguilera S, Urzua U, Munroe D, Molina C, et al. Gene expression and chromosomal location for susceptibility to Sjogren's syndrome. J Autoimmun. 2009;33(2):99–108. doi: 10.1016/j.jaut.2009.05.001 19523788
38. Li H, Ice JA, Lessard CJ, Sivils KL, Interferons in Sjogren's Syndrome: Genes, Mechanisms, and Effects. Front Immunol. 2013;4:290. doi: 10.3389/fimmu.2013.00290 24062752
39. International Consortium for Systemic Lupus Erythematosus GeneticsHarley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008;40(2):204–10. doi: 10.1038/ng.81 18204446
40. Lessard CJ, Adrianto I, Ice JA, Wiley GB, Kelly JA, Glenn SB, et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet. 2012;90(4):648–60. doi: 10.1016/j.ajhg.2012.02.023 22464253
41. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010;42(6):508–14. doi: 10.1038/ng.582 20453842
42. Miceli-Richard C, Comets E, Loiseau P, Puechal X, Hachulla E, Mariette X, Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum. 2007;56(12):3989–94. doi: 10.1002/art.23142 18050197
43. Nordmark G, Kristjansdottir G, Theander E, Eriksson P, Brun JG, Wang C, et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome. Genes & Immunity. 2009;10(1):68–76.
44. Lien C, Fang CM, Huso D, Livak F, Lu R, Pitha PM, Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci U S A. 2010;107(10):4664–8. doi: 10.1073/pnas.0911193107 20176957
45. Wang J, Basagoudanavar SH, Wang X, Hopewell E, Albrecht R, Garcia-Sastre A, et al. NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication. J Immunol. 2010;185(3):1720–9. doi: 10.4049/jimmunol.1000114 20610653
46. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106(23):9362–7. doi: 10.1073/pnas.0903103106 19474294
47. Gupta RM, Musunuru K, Mapping novel pathways in cardiovascular disease using eQTL data: the past, present, and future of gene expression analysis. Front Genet. 2012;3:232. doi: 10.3389/fgene.2012.00232 23755065
48. Encode Project ConsortiumAn integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74. doi: 10.1038/nature11247 22955616
49. Kabakchiev B, Silverberg MS, Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine. Gastroenterology. 2013;144(7):1488–96, 96 e1–3. doi: 10.1053/j.gastro.2013.03.001 23474282
50. Kim Y, Xia K, Tao R, Giusti-Rodriguez P, Vladimirov V, van den Oord E, et al. A meta-analysis of gene expression quantitative trait loci in brain. Transl Psychiatry. 2014;4:e459. doi: 10.1038/tp.2014.96 25290266
51. Bonnevie-Nielsen V, Field LL, Lu S, Zheng DJ, Li M, Martensen PM, et al. Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet. 2005;76(4):623–33. doi: 10.1086/429391 15732009
52. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12(6):996–1006. doi: 10.1101/gr.229102 12045153
53. Hormozdiari F, Kostem E, Kang EY, Pasaniuc B, Eskin E, Identifying causal variants at loci with multiple signals of association. Genetics. 2014;198(2):497–508. doi: 10.1534/genetics.114.167908 25104515
54. Kjaer KH, Pahus J, Hansen MF, Poulsen JB, Christensen EI, Justesen J, et al. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism. BMC Cell Biol. 2014;15:33. doi: 10.1186/1471-2121-15-33 25205466
55. Lalonde E, Ha KC, Wang Z, Bemmo A, Kleinman CL, Kwan T, et al. RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression. Genome Res. 2011;21(4):545–54. doi: 10.1101/gr.111211.110 21173033
56. Noguchi S, Hamano E, Matsushita I, Hijikata M, Ito H, Nagase T, et al. Differential effects of a common splice site polymorphism on the generation of OAS1 variants in human bronchial epithelial cells. Hum Immunol. 2013;74(3):395–401. doi: 10.1016/j.humimm.2012.11.011 23220500
57. Trapnell C, Pachter L, Salzberg SL, TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25(9):1105–11. doi: 10.1093/bioinformatics/btp120 19289445
58. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28(5):511–5. doi: 10.1038/nbt.1621 20436464
59. Cagliani R, Fumagalli M, Guerini FR, Riva S, Galimberti D, Comi GP, et al. Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis. Hum Genet. 2012;131(1):87–97. doi: 10.1007/s00439-011-1053-2 21735172
60. Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B, et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 2009;5(2):e1000321. doi: 10.1371/journal.ppat.1000321 19247438
61. Zhao Y, Kang H, Ji Y, Chen X, Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis. Clin Exp Med. 2013;13(3):171–6. doi: 10.1007/s10238-012-0193-6 22710942
62. Hovanessian AG, Justesen J, The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation. Biochimie. 2007;89(6–7):779–88. doi: 10.1016/j.biochi.2007.02.003 17408844
63. Silverman RH, A scientific journey through the 2-5A/RNase L system. Cytokine Growth Factor Rev. 2007;18(5–6):381–8. doi: 10.1016/j.cytogfr.2007.06.012 17681844
64. Hung T, Pratt GA, Sundararaman B, Townsend MJ, Chaivorapol C, Bhangale T, et al. The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression. Science. 2015;350(6259):455–9. doi: 10.1126/science.aac7442 26382853
65. Weller ML, Gardener MR, Bogus ZC, Smith MA, Astorri E, Michael DG, et al. Hepatitis Delta Virus Detected in Salivary Glands of Sjogren's Syndrome Patients and Recapitulates a Sjogren's Syndrome-Like Phenotype in Vivo. Pathog Immun. 2016;1(1):12–40. 27294212
66. Ding M, Zhang J, Epitope spreading induced by immunization with synthetic SSB peptides. Exp Ther Med. 2016;12(1):147–50. doi: 10.3892/etm.2016.3267 27347030
67. Paisansinsup T, Deshmukh US, Chowdhary VR, Luthra HS, Fu SM, David CS, HLA class II influences the immune response and antibody diversification to Ro60/Sjogren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J Immunol. 2002;168(11):5876–84. 12023392
68. Szymula A, Rosenthal J, Szczerba BM, Bagavant H, Fu SM, Deshmukh US, T cell epitope mimicry between Sjogren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol. 2014;152(1–2):1–9. doi: 10.1016/j.clim.2014.02.004 24576620
69. Albert LJ, Inman RD, Molecular mimicry and autoimmunity. N Engl J Med. 1999;341(27):2068–74. doi: 10.1056/NEJM199912303412707 10615080
70. Justesen J, Hartmann R, Kjeldgaard NO, Gene structure and function of the 2'-5'-oligoadenylate synthetase family. Cell Mol Life Sci. 2000;57(11):1593–612. 11092454
71. Imran M, Manzoor S, Khattak NM, Tariq M, Khalid M, Javed F, et al. Correlation of OAS1 gene polymorphism at exon 7 splice accepter site with interferon-based therapy of HCV infection in Pakistan. Viral Immunol. 2014;27(3):105–11. doi: 10.1089/vim.2013.0107 24673406
72. Bader El Din NG, Anany MA, Dawood RM, Ibrahim MK, El-Shenawy R, El Abd YS, et al. Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients. Viral Immunol. 2015;28(9):509–16. doi: 10.1089/vim.2015.0041 26505957
73. Ghosh A, Sarkar SN, Guo W, Bandyopadhyay S, Sen GC, Enzymatic activity of 2'-5'-oligoadenylate synthetase is impaired by specific mutations that affect oligomerization of the protein. J Biol Chem. 1997;272(52):33220–6. 9407111
74. Mullan PB, Hosey AM, Buckley NE, Quinn JE, Kennedy RD, Johnston PG, et al. The 2,5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1- and interferon-gamma-mediated apoptosis. Oncogene. 2005;24(35):5492–501. doi: 10.1038/sj.onc.1208698 15940267
75. Ghosh A, Sarkar SN, Rowe TM, Sen GC, A specific isozyme of 2'-5' oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family. J Biol Chem. 2001;276(27):25447–55. doi: 10.1074/jbc.M100496200 11323417
76. Jauharoh SN, Saegusa J, Sugimoto T, Ardianto B, Kasagi S, Sugiyama D, et al. SS-A/Ro52 promotes apoptosis by regulating Bcl-2 production. Biochem Biophys Res Commun. 2012;417(1):582–7. doi: 10.1016/j.bbrc.2011.12.010 22178074
77. Kamachi M, Kawakami A, Yamasaki S, Hida A, Nakashima T, Nakamura H, et al. Regulation of apoptotic cell death by cytokines in a human salivary gland cell line: distinct and synergistic mechanisms in apoptosis induced by tumor necrosis factor alpha and interferon gamma. J Lab Clin Med. 2002;139(1):13–9. 11873240
78. Rogozin IB, Aravind L, Koonin EV, Differential action of natural selection on the N and C-terminal domains of 2'-5' oligoadenylate synthetases and the potential nuclease function of the C-terminal domain. J Mol Biol. 2003;326(5):1449–61. 12595257
79. O'Brien M, Lonergan R, Costelloe L, O'Rourke K, Fletcher JM, Kinsella K, et al. OAS1: a multiple sclerosis susceptibility gene that influences disease severity. Neurology. 2010;75(5):411–8. doi: 10.1212/WNL.0b013e3181ebdd2b 20679634
80. Consortium GTThe Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580–5. doi: 10.1038/ng.2653 23715323
81. Field LL, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen TB, Beck-Nielsen H, OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes. 2005;54(5):1588–91. 15855350
82. Miceli-Richard C, Gestermann N, Simoneta F, Boudaoud S, Nocturne G, Lecluze Y, et al. Interleukin 12 Is Involved in an Interferon Type I Signature Through Crosstalk of CD4+ T Cells and Plasmacytoid Dendritic Cells. Arthritis Rheum. 2012;64:Abstract 2321.
83. Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, Pine R, et al. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J Immunol. 1996;157(11):4781–9. 8943379
84. Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A, et al. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science. 2002;297(5589):2063–6. doi: 10.1126/science.1074900 12242445
85. Lawless VA, Zhang S, Ozes ON, Bruns HA, Oldham I, Hoey T, et al. Stat4 regulates multiple components of IFN-gamma-inducing signaling pathways. J Immunol. 2000;165(12):6803–8. 11120802
86. Barnes BJ, Moore PA, Pitha PM, Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem. 2001;276(26):23382–90. doi: 10.1074/jbc.M101216200 11303025
87. Westra H-J, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013;45(10):1238–43. doi: 10.1038/ng.2756 24013639
88. Pickrell JK, Marioni JC, Pai AA, Degner JF, Engelhardt BE, Nkadori E, et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature. 2010;464(7289):768–72. doi: 10.1038/nature08872 20220758
89. Fairfax BP, Humburg P, Makino S, Naranbhai V, Wong D, Lau E, et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science. 2014;343(6175):1246949. doi: 10.1126/science.1246949 24604202
90. Rasmussen A, Ice JA, Li H, Grundahl K, Kelly JA, Radfar L, et al. Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis. 2014;73(1):31–8. doi: 10.1136/annrheumdis-2013-203845 23968620
91. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75. doi: 10.1086/519795 17701901
92. Kauffmann A, Gentleman R, Huber W, arrayQualityMetrics—a bioconductor package for quality assessment of microarray data. Bioinformatics. 2009;25(3):415–6. doi: 10.1093/bioinformatics/btn647 19106121
93. Barbosa-Morais NL, Dunning MJ, Samarajiwa SA, Darot JF, Ritchie ME, Lynch AG, et al. A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data. Nucleic Acids Res. 2010;38(3):e17. doi: 10.1093/nar/gkp942 19923232
94. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249–64. doi: 10.1093/biostatistics/4.2.249 12925520
95. Johnson WE, Li C, Rabinovic A, Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118–27. doi: 10.1093/biostatistics/kxj037 16632515
96. de Hoon MJ, Imoto S, Nolan J, Miyano S, Open source clustering software. Bioinformatics. 2004;20(9):1453–4. doi: 10.1093/bioinformatics/bth078 14871861
97. Saldanha AJ, Java Treeview—extensible visualization of microarray data. Bioinformatics. 2004;20(17):3246–8. doi: 10.1093/bioinformatics/bth349 15180930
98. International HapMap ConsortiumFrazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449(7164):851–61. doi: 10.1038/nature06258 17943122
99. Howie BN, Donnelly P, Marchini J, A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5(6):e1000529. doi: 10.1371/journal.pgen.1000529 19543373
100. Via M, Gignoux C, Burchard EG, The 1000 Genomes Project: new opportunities for research and social challenges. Genome Med. 2010;2(1):3. doi: 10.1186/gm124 20193048
101. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D, Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904–9. doi: 10.1038/ng1847 16862161
102. McKeigue PM, Carpenter JR, Parra EJ, Shriver MD, Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations. Ann Hum Genet. 2000;64(Pt 2):171–86. doi: 10.1017/S0003480000008022 11246470
103. Halder I, Shriver M, Thomas M, Fernandez JR, Frudakis T, A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications. Hum Mutat. 2008;29(5):648–58. doi: 10.1002/humu.20695 18286470
104. Cattell RB, The Scree test for the number of factors. Multivariate Behav Res. 1966;1(2):245–76. doi: 10.1207/s15327906mbr0102_10 26828106
105. Willer CJ, Li Y, Abecasis GR, METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190–1. doi: 10.1093/bioinformatics/btq340 20616382
106. Barrett JC, Fry B, Maller J, Daly MJ, Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–5. doi: 10.1093/bioinformatics/bth457 15297300
107. Shabalin AA, Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics. 2012;28(10):1353–8. doi: 10.1093/bioinformatics/bts163 22492648
108. Stegle O, Parts L, Durbin R, Winn J, A Bayesian framework to account for complex non-genetic factors in gene expression levels greatly increases power in eQTL studies. PLoS Comput Biol. 2010;6(5):e1000770. doi: 10.1371/journal.pcbi.1000770 20463871
109. Anders S, Huber W, Differential expression analysis for sequence count data. Genome Biol. 2010;11(10):R106. doi: 10.1186/gb-2010-11-10-r106 20979621
110. Thorvaldsdottir H, Robinson JT, Mesirov JP, Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14(2):178–92. doi: 10.1093/bib/bbs017 22517427
111. Schulze-Koops H, Lymphopenia and autoimmune diseases. Arthritis Res Ther. 2004;6(4):178–80. doi: 10.1186/ar1208 15225363
112. Le Campion A, Gagnerault MC, Auffray C, Becourt C, Poitrasson-Riviere M, Lallemand E, et al. Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development. Blood. 2009;114(9):1784–93. doi: 10.1182/blood-2008-12-192120 19561321
113. Zhang N, Bevan MJ, TGF-beta signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol. 2012;13(7):667–73. doi: 10.1038/ni.2319 22634866